The city of Kansas City, Kansas, currently has 1 active clinical trials seeking participants for Type 2 Diabetes research studies.
Knee Osteoarthritis Treatment with Zilretta Vs. Kenalog in the Context of Type II Diabetes
Recruiting
A Phase 2 Randomized Study to Evaluate the Effects of triamcinolone acetonide extended-release (TA-ER; Zilretta) vs. triamcinolone acetonide immediate-release (TA-IR; Kenalog) on Blood Glucose Levels in Diabetic Subjects with Knee Osteoarthritis. Subjects should have Type 2 Diabetes Mellitus (T2DM) with HbA1C ≤9 that is managed without insulin and have been diagnosed with symptomatic unilateral or bilateral osteoarthritis (OA) of the knee, based on clinical and radiological criteria (if bilatera... Read More
Gender:
ALL
Ages:
40 years and above
Trial Updated:
09/17/2024
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Osteoarthritis, Knee, Diabetes Mellitus, Type 2